ArticleCancer research communications2023

IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance.

Zoë Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.